Kalayoglu Murat

CIK 00020000021 companyWASHINGTON, DC

SEC Profile

Transactions

Companies

Filings

CIK

0002000002

Recent Transactions

19 trades

Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Series A Non-Voting Convertible Preferred Stock
2026-04-02−22,740.03→ 33,662.224 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2026-04-02+758,001→ 5,313,261 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2026-01-02+7,800→ 7,800 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2026-01-02+2,600→ 511,577 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2025-01-02+7,800→ 7,800 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-02+2,600→ 508,977 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Series A Non-Voting Convertible Preferred Stock
2024-10-11−45,551.19→ 56,402.254 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-10-11+1,518,373→ 4,555,260 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Series A Non-Voting Convertible Preferred Stock
2024-04-08−14,755.609→ 0 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-04-08+491,853→ 506,377 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-04-08+2,926,764→ 3,036,887 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Series A Non-Voting Convertible Preferred Stock
2024-04-08−87,802.95→ 101,953.444 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-01-02+228,000→ 228,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-01-02+178,000→ 435,739 total
Other
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-11-13+3,303,699→ 3,303,699 total
Purchase
Cartesian Therapeutics, Inc.$RNAC
Series A Non-Voting Convertible Preferred Stock
2023-11-13$249999.98/sh+619.627→ 619.627 total
Other
Cartesian Therapeutics, Inc.$RNAC
Series A Non-Voting Convertible Preferred Stock
2023-11-13+189,136.767→ 189,136.767 total
Award
Cartesian Therapeutics, Inc.$RNAC
Series A Non-Voting Convertible Preferred Stock
2023-11-13+14,755.609→ 14,755.609 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-11-13+257,739→ 257,739 total

Companies

Cartesian Therapeutics, Inc.
10% Owner
$RNAC

Recent Filings

Address

C/O SOAR BIO, LLC 7144 13TH PL NW

WASHINGTON, DC, 20012

View on SEC.gov